Cencora, Inc. logo

Cencora, Inc. (COR)

Market Open
11 Aug, 13:36
NYSE NYSE
$
332. 43
+7.43
+2.2862%
$
59.59B Market Cap
23.39 P/E Ratio
2.4% Div Yield
38,705 Volume
11.93 Eps
$ 325
Previous Close
Add Transaction
Day Range
324.3 332.43
Year Range
244.82 377.54
Want to track COR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript

Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript

Cencora, Inc. (COR) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 months ago
COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised

COR Stock Falls on Q2 Earnings & Revenue Miss, FY26 EPS View Raised

Cencora shares sink after Q2 earnings and revenues miss estimates, even as the company raises its fiscal 2026 EPS outlook.

Zacks | 3 months ago
Cencora (COR) Misses Q2 Earnings and Revenue Estimates

Cencora (COR) Misses Q2 Earnings and Revenue Estimates

Cencora (COR) came out with quarterly earnings of $4.75 per share, missing the Zacks Consensus Estimate of $4.8 per share. This compares to earnings of $4.42 per share a year ago.

Zacks | 3 months ago
Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Seeking Clues to Cencora (COR) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2026.

Zacks | 3 months ago
Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth

Cencora (COR) Reports Next Week: Wall Street Expects Earnings Growth

Cencora (COR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 3 months ago
All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside

Cencora (COR) gets its prior buy rating from 2025 reaffirmed, driven by several strong fundamentals, despite a recent price retreat. The healthcare distributor has a global brand footprint, a key role in serving specific clinical needs, and profitability, despite thin margins. The dividend case is compelling, with proven 10 year growth across many market cycles, and a low payout ratio.

Seekingalpha | 4 months ago
COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal

COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal

Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.

Zacks | 4 months ago
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.

Zacks | 4 months ago
California Public Employees Retirement System Has $184.01 Million Stock Holdings in Cencora, Inc. $COR

California Public Employees Retirement System Has $184.01 Million Stock Holdings in Cencora, Inc. $COR

California Public Employees Retirement System lowered its stake in Cencora, Inc. (NYSE: COR) by 13.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 588,788 shares of the company's stock after selling 93,334 shares during the quarter. California Public Employees Retirement

Defenseworld | 4 months ago
Chilton Investment Co. Inc. Purchases New Holdings in Cencora, Inc. $COR

Chilton Investment Co. Inc. Purchases New Holdings in Cencora, Inc. $COR

Chilton Investment Co. Inc. acquired a new stake in shares of Cencora, Inc. (NYSE: COR) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,468 shares of the company's stock, valued at approximately $459,000. Other hedge funds and other

Defenseworld | 4 months ago
Alliancebernstein L.P. Has $278.09 Million Stake in Cencora, Inc. $COR

Alliancebernstein L.P. Has $278.09 Million Stake in Cencora, Inc. $COR

Alliancebernstein L.P. lowered its position in Cencora, Inc. (NYSE: COR) by 21.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 889,802 shares of the company's stock after selling 244,496 shares during the period. Alliancebernstein L.P. owned 0.46% of Cencora worth

Defenseworld | 4 months ago
Glenmede Investment Management LP Sells 4,232 Shares of Cencora, Inc. $COR

Glenmede Investment Management LP Sells 4,232 Shares of Cencora, Inc. $COR

Glenmede Investment Management LP reduced its stake in Cencora, Inc. (NYSE: COR) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 169,665 shares of the company's stock after selling 4,232 shares during the quarter. Glenmede Investment Management

Defenseworld | 5 months ago
Loading...
Load More